Stocks and Investing Stocks and Investing
Fri, July 16, 2021

David Lebovitz Maintained (ALNY) at Buy with Increased Target to $224 on, Jul 16th, 2021


Published on 2024-10-27 17:13:21 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $205 to $224 on, Jul 16th, 2021.

David, nor any peers, have made any analyst calls on ALNY in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources